References
- Litjens RP, Brunt TM. How toxic is ibogaine? Clin Toxicol (Phila). 2016;25:1–6.
- Lotsof HS, Alexander NE. Case studies of ibogaine treatment: implications for patient management strategies. Alkaloids Chem Biol. 2001;56:293–313.
- Alper KR, Stajić M, Gill JR. Fatalities temporally associated with the ingestion of ibogaine. J Forensic Sci. 2012;57:398–412.
- Mash DC, Kovera CA, Pablo J, et al. Ibogaine in the treatment of heroin withdrawal. Alkaloids Chem Biol. 2001;56:155–171.
- Glick SD, Sell EM, Maisonneuve IM. Brain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration. Eur J Pharmacol. 2008;599:91–95.
- Alper K, Bai R, Liu N, et al. hERG blockade by iboga alkaloids. Cardiovasc Toxicol. 2016;16:14–22.